NasdaqGM - Nasdaq Real Time Price USD
Actuate Therapeutics, Inc. Common stock (ACTU)
8.96
-0.13
(-1.43%)
At close: June 6 at 4:00:01 PM EDT
9.21
+0.25
+(2.79%)
After hours: June 6 at 5:43:02 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 3 |
| Avg. Estimate | -0.31 | -0.3 | -1.25 | -1.33 |
| Low Estimate | -0.34 | -0.32 | -1.31 | -1.67 |
| High Estimate | -0.29 | -0.28 | -1.2 | -0.98 |
| Year Ago EPS | -- | -- | -3.26 | -1.25 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2024 | 3/31/2025 |
|---|---|---|
| EPS Est. | -0.29 | -0.3 |
| EPS Actual | -- | -0.32 |
| Difference | -- | -0.02 |
| Surprise % | -- | -5.50% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.31 | -0.3 | -1.25 | -1.33 |
| 7 Days Ago | -0.31 | -0.3 | -1.25 | -1.33 |
| 30 Days Ago | -0.28 | -0.26 | -1.14 | -1.37 |
| 60 Days Ago | -0.27 | -0.25 | -1.12 | -1.38 |
| 90 Days Ago | 0 | 0 | -1.2 | -1.49 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 1 | 1 |
| Up Last 30 Days | 1 | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ACTU | -- | -- | 61.50% | -6.24% |
| S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Upgrades & Downgrades
| Initiated | HC Wainwright & Co.: Buy | 3/17/2025 |
Related Tickers
PDSB PDS Biotechnology Corporation
1.6900
+8.33%
BCAX Bicara Therapeutics Inc.
11.50
+4.26%
ANAB AnaptysBio, Inc.
23.70
+12.11%
RNTX Rein Therapeutics Inc.
2.0000
+2.56%
TRVI Trevi Therapeutics, Inc.
7.06
+4.75%
IMMX Immix Biopharma, Inc.
2.3700
+8.22%
CGEM Cullinan Therapeutics, Inc.
9.08
+3.89%
APTOF Aptose Biosciences Inc.
1.7400
-1.14%
IMTX Immatics N.V.
5.97
+3.29%
INAB IN8bio, Inc.
4.1700
+15.74%